concern
transfusiontransmit
infecti
diseas
ttid
rais
sinc
begin
routin
blood
administr
therapeut
purpos
late
syphili
first
transmiss
diseas
prospect
blood
donor
test
implement
although
infecti
posttransfus
hepat
pth
recogn
describ
earli
believ
transient
gener
minor
infecti
complic
intervent
reduc
pth
occur
discoveri
hepat
b
viru
hepat
c
viru
decad
later
awar
infecti
diseas
transmiss
transfus
slow
dramat
increas
administr
donat
blood
parallel
expans
medic
care
procedur
capabl
period
given
widespread
use
transfus
earli
realiz
newlydiscov
fatal
acquir
immunodefici
syndrom
could
transmit
transfus
came
shock
transfus
medicin
specialist
public
sinc
effort
protect
blood
suppli
virus
caus
aid
hiv
pth
result
unparallel
focu
resourc
attent
character
detect
prevent
ttid
commit
paid
blood
safeti
histor
unpreced
level
least
highincom
countri
tabl
howev
public
uneasi
concern
among
health
profession
diseas
transmiss
transfus
persist
concern
caus
redirect
attent
classic
ttid
emerg
infect
purpos
review
author
appli
term
broadli
includ
recent
discov
entiti
variant
creutzfeldtjacob
diseas
sever
acut
respiratori
syndrom
sar
transmiss
transfus
unprov
longerknown
pathogen
west
nile
viru
newli
recogn
agent
caus
ttid
condit
bacteri
contamin
malaria
concern
sinc
begin
transfus
therapi
emerg
press
concern
classic
ttid
nearli
elimin
author
follow
taxonom
order
review
variou
pathogen
articl
close
brief
reflect
challeng
pose
new
emerg
pathogen
outlin
gener
approach
pursu
protect
blood
suppli
abbrevi
hbv
hepat
b
viru
hcv
hepat
c
viru
nat
nucleic
acid
test
estim
hbv
reflect
risk
project
prior
implement
blood
donor
screen
nat
b
estim
hiv
hcv
indic
risk
project
follow
implement
nat
agent
c
risk
estim
reflect
experi
unit
state
nation
studi
prior
implement
standard
detect
limit
bacteri
contamin
like
underreport
true
risk
probabl
higher
hepat
b
viru
hbv
hepat
c
viru
hcv
member
hepadna
flaviviru
famili
respect
two
classic
known
transfusiontransmit
virus
ttv
therefor
consid
articl
detail
inform
found
recent
review
hepat
origin
call
delta
agent
defect
rnacontain
passeng
viru
requir
hbv
act
helper
assembl
envelop
protein
screen
hbv
prevent
transfusionassoci
hepat
case
identifi
donor
coinfect
hepat
b
virus
primarili
transmit
via
fecalor
rout
caus
frequent
epidem
acut
hepat
develop
countri
occasion
focal
outbreak
unit
state
develop
countri
virem
period
gener
brief
although
least
case
hepat
viru
hav
viremia
may
present
day
onset
symptom
longer
previous
realiz
prolong
carrier
state
describ
parenter
transmiss
rare
neither
hav
hepat
e
viru
hev
consid
bloodborn
pathogen
strict
sens
anim
inocul
studi
one
recent
report
human
document
transmiss
hev
transfus
fresh
compon
although
risk
undoubtedli
small
given
rariti
report
high
preval
infect
mani
develop
countri
hand
case
transfusiontransmit
hav
well
document
estim
occur
rate
less
approxim
per
million
unit
transfus
greater
concern
contamin
plasma
deriv
albumin
gamma
globulin
prepar
clot
factor
concentr
hav
pool
thousand
plasma
donat
manufactur
plasma
deriv
rel
resist
hav
inactiv
even
rare
instanc
donor
viremia
lead
widespread
contamin
product
consequ
hav
caus
sever
outbreak
clinic
diseas
contamin
coagul
factor
prepar
albumin
plasma
protein
fraction
immun
globulin
prepar
howev
implic
hav
transmiss
manufactur
process
product
partit
viru
differ
plasma
fraction
presenc
antihav
immun
globulin
prepar
expect
protect
residu
infecti
hav
enter
product
newer
viral
inactiv
method
nucleic
acid
test
nat
pool
plasma
sampl
promis
protect
hav
transmiss
mean
plasma
product
remot
risk
hav
transmiss
transfus
screen
blood
donor
use
nat
technolog
recommend
vast
major
posttransfus
hepat
case
attribut
known
e
hepat
virus
mostli
hbv
hcv
occasion
case
howev
appear
caus
yet
undiscov
agent
sever
novel
candid
virus
identifi
hepat
g
viru
gbvc
member
flavivirida
famili
transmit
predominantli
parenter
rout
infect
occur
frequent
among
infect
hcv
hiv
approxim
blood
donor
injectiondrug
user
unit
state
detect
gbvc
rna
addit
person
antibodi
envelop
protein
absenc
gbvc
rna
suggest
viral
clearanc
epidemiolog
studi
shown
associ
gbvc
infect
liver
diseas
demonstr
delay
diseas
progress
coinfect
hiv
intrigu
observ
yet
fulli
understood
tt
viru
nonenvelop
dna
viru
discov
preval
north
america
transmit
transfus
presenc
yet
correl
liver
diseas
anoth
entiti
sen
viru
senv
identifi
investig
patient
possibl
tt
viru
agent
member
circoviru
famili
character
circular
dna
contain
nonenvelop
round
nucleocapsid
despit
initi
report
two
patient
transfusionassoci
nona
e
hepat
harbor
senv
variant
senvd
senvh
subsequ
report
fail
link
senv
clinic
hepat
date
neither
gbvc
tt
viru
senv
born
initi
indic
repres
clinic
signific
virus
henc
donor
screen
implement
expect
identif
new
put
hepat
virus
continu
perhap
close
perceiv
gap
list
known
caus
agent
infecti
hepat
sinc
first
report
hiv
transmiss
transfus
appear
earli
retroviru
name
revers
transcriptas
enzym
allow
retrovirus
transcrib
viral
rna
dna
insert
host
genom
becom
best
known
ttv
dramat
impact
public
percept
blood
safeti
owe
seri
increment
effect
prevent
measur
risk
hivtransfusiontransmit
infect
declin
remark
highincom
countri
estim
mathemat
model
recent
estim
project
residu
risk
approxim
million
transfus
blood
donor
screen
current
avail
antibodi
nucleic
acid
assay
highli
sensit
reliabl
unfortun
lowincom
nation
mani
burden
appallingli
high
preval
hiv
lack
resourc
infrastructur
screen
blood
suppli
consist
contamin
hiv
ttv
rate
hiv
infect
still
reach
new
popul
particularli
eastern
europ
asia
hiv
qualifi
emerg
viru
part
world
anoth
caus
concern
appear
new
subtyp
overal
increas
genet
divers
hiv
blood
donor
screen
test
initi
develop
valid
detect
main
group
group
subtyp
b
viru
reflect
predomin
hiv
strain
north
america
europ
worldwid
howev
nonsubtyp
b
strain
group
predomin
past
exist
antibodi
assay
perform
well
nonsubtyp
b
viral
strain
caus
concern
infect
strain
could
miss
ongo
surveil
studi
monitor
emerg
new
hiv
variant
effect
routin
hiv
test
kit
detect
virus
human
tlymphotrop
viru
ii
htlvi
ii
close
relat
retrovirus
oncovirina
group
identifi
ttv
shortli
discoveri
hiv
hiv
risk
htlv
transmiss
transfus
plummet
unit
state
sinc
late
blood
donor
screen
began
result
virus
current
consid
rise
threat
transfusionsafeti
perspect
human
herp
virus
hhv
envelop
structur
complex
doublestrand
dna
virus
caus
common
infecti
diseas
usual
associ
lifelong
carrier
state
possibl
recurr
reactiv
infect
classifi
three
subfamili
alpha
beta
gammaherpesvirina
beta
herp
viru
cytomegaloviru
cmv
figur
promin
current
transfus
practic
use
blood
product
cmv
seroneg
donor
patient
high
risk
seriou
cmv
diseas
eg
stem
cell
transplant
recipi
major
strategi
prevent
cmv
transfus
complic
past
decad
sinc
cmv
transmiss
transfus
gener
requir
transfer
infect
leukocyt
overal
risk
cmv
transmiss
expect
declin
significantli
sinc
transit
toward
allleukocytereduc
blood
suppli
highincom
nation
recent
year
although
epstein
barr
viru
ebv
also
transmit
transfus
ebv
ubiquit
donor
recipi
transfus
acquisit
gener
asymptomat
associ
benign
cours
among
hhv
gamma
herp
viru
link
kaposi
sarcoma
bodycavitybas
lymphoma
castleman
diseas
might
consid
emerg
pathogen
viru
tropism
lymphocyt
monocytemacrophag
shown
transmit
transplant
definit
evid
transmiss
transfus
lack
howev
seropreval
among
unit
state
blood
donor
report
region
studi
high
howev
recent
multicent
studi
donor
five
repres
unit
state
region
involv
seven
stateoftheart
assay
found
seropreval
evid
donor
viremia
find
agreement
epidemiolog
studi
suggest
sexual
contact
prefer
rout
transmiss
wherea
bloodborn
transmiss
unlik
event
greater
potenti
transmiss
transfus
may
exist
subsaharan
africa
dna
report
approxim
investig
blood
donor
fresh
nonleukoreduc
transfus
common
practic
parvoviru
nonenvelop
dna
viru
known
transmit
transfus
decad
recent
attract
attent
realiz
viremia
rel
common
blood
donor
inactiv
viru
easi
reliabl
recipi
blood
blood
product
includ
patient
popul
increasingli
vulner
infect
sequela
viru
caus
exanthemat
ill
call
fifth
diseas
infant
gener
asymptomat
acut
infect
adult
infect
occur
year
age
approxim
adult
seroposit
parvoviru
antibodi
viru
classifi
erythroviru
reflect
tropism
erythroid
progenitor
cell
receptor
erythrocyt
p
antigen
p
antigen
express
megakaryocyt
endothelium
placenta
fetal
liver
fetal
heart
cell
erythroid
precursor
cell
suscept
follow
infect
neutral
antibodi
appear
patient
sickl
cell
anemia
thalassemia
condit
associ
shorten
red
cell
surviv
risk
develop
acut
aplast
hypoplast
anemia
follow
infect
other
risk
aplasia
follow
parvoviru
infect
includ
immunodefici
patient
hivinfect
patient
solid
organ
transplant
recipi
children
malign
immunocompromis
patient
may
develop
sever
chronic
anemia
due
persist
parvoviru
infect
acut
parvoviru
infect
pregnanc
may
result
fetal
loss
neurolog
abnorm
congenit
infect
red
blood
cell
aplasia
chronic
anemia
due
parvoviru
infect
often
respond
infus
immun
globulin
prepar
parvoviru
expect
present
blood
donor
significantli
higher
incid
epidem
period
howev
protect
antibodi
frequent
present
donor
recipi
occasion
transmiss
parvoviru
due
singledonor
compon
report
hand
transmiss
plasmaderiv
product
signific
concern
near
ubiqu
viru
larg
plasma
pool
sourc
materi
plasma
product
resist
common
inactiv
method
although
presenc
neutral
antibodi
plasma
pool
provid
protect
guarante
recipi
infect
prospect
studi
previous
untreat
hemophil
patient
receiv
virusattenu
factor
concentr
demonstr
persist
risk
parvoviru
infect
fortun
patient
gener
suffer
seriou
longterm
hematolog
sequela
regardless
hiv
serostatu
parvoviru
dna
also
detect
albumin
prepar
earlier
studi
suggest
routin
pasteur
step
c
manufactur
process
may
effect
inactiv
viru
howev
recent
studi
use
cell
cultur
system
human
parvoviru
indic
viru
rapidli
destroy
heat
consist
good
safeti
record
albumin
regard
parvoviru
transmiss
recent
implement
nat
screen
sourc
plasma
exclud
highlevel
virem
donat
use
manufactur
promis
reduc
risk
parvoviru
infect
product
elimin
viru
manufactur
plasma
product
may
enabl
develop
effect
nanofiltr
method
sever
recent
highli
public
outbreak
communic
diseas
human
includ
sar
monkey
pox
infect
avian
influenza
caus
virus
usual
found
anim
highlight
problem
appar
increas
speciestospeci
transmiss
pathogen
virus
phenomenon
term
zoonosi
also
respons
epidem
hiv
deriv
simian
immunodefici
virus
htlv
deriv
simian
tlymphotrop
virus
zoonot
transmiss
epidem
expect
continu
perhap
increas
futur
factor
shrink
natur
habitat
increas
human
activ
around
wildlif
frequent
intern
travel
trade
migrat
human
expos
new
virus
way
lack
immun
popul
potenti
caus
devast
pandem
past
global
outbreak
influenza
ongo
aid
pandem
except
west
nile
viru
discuss
detail
later
articl
none
virus
may
consid
emerg
human
pathogen
bloodborn
organ
classic
sens
therefor
like
transmit
transfus
nevertheless
episod
viremia
document
sar
prompt
temporari
prophylact
deferr
blood
donor
risk
diseas
sar
probabl
unusu
respect
assum
period
asymptomat
viremia
also
occur
zoonot
infect
caus
diseas
outbreak
human
anoth
unknown
potenti
threat
zoonot
virus
might
acquir
new
mutat
adapt
human
host
could
chang
mode
transmiss
alter
properti
increas
transmiss
pathogen
gener
recent
object
concern
regard
emerg
viral
infect
transfus
well
known
human
virus
caus
common
communic
diseas
enterovirus
although
may
caus
symptomat
infect
mild
selflimit
diseas
healthi
adult
caus
sever
symptom
vulner
popul
infant
immunosuppress
patient
elderli
research
scotland
identifi
season
fluctuat
viremia
involv
enteroviru
speci
approxim
scottish
blood
donor
fig
signific
find
diseas
transmiss
need
routin
donor
screen
prevent
measur
protect
blood
suppli
yet
establish
obviou
area
investig
west
nile
viru
wnv
singlestrand
rna
viru
flaviviru
famili
member
japanes
enceph
viru
serocomplex
includ
japanes
enceph
viru
st
loui
enceph
viru
virus
complex
arthropodborn
arbovirus
ie
transmit
mosquito
arthropod
vector
potenti
caus
meningoenceph
wnv
first
isol
west
nile
district
northern
uganda
deriv
name
region
next
sever
decad
geograph
rang
found
extend
eastern
southern
europ
africa
middl
east
includ
israel
russia
western
southern
asia
especi
india
natur
life
cycl
viru
includ
certain
speci
femal
mosquito
vector
bird
serv
primari
vertebr
host
replic
viru
high
titer
amplifi
host
human
mammal
particularli
hors
incident
host
transmiss
occur
bite
infect
mosquito
peak
transmiss
occur
late
summer
earli
fall
case
wnv
infect
north
america
entir
western
hemispher
wnv
outbreak
new
york
citi
summer
viru
becam
dormant
winter
month
reemerg
caus
small
number
human
case
summer
howev
much
larger
epidem
occur
unit
state
signific
geograph
spread
includ
westward
migrat
fig
case
death
report
state
transmiss
wnv
transfus
consid
biolog
plausibl
given
asymptomat
wnv
infect
associ
brief
period
viremia
late
august
case
wnv
transmiss
organ
donor
four
recipi
document
evid
obtain
indic
organ
donor
like
infect
one
transfus
given
organ
harvest
next
sever
month
intens
investig
confirm
case
transfusiontransmit
wnv
infect
unit
state
summer
fall
twelv
transfus
recipi
develop
meningoenceph
sever
die
type
blood
compon
red
blood
cell
platelet
fresh
frozen
plasma
transmit
infect
sever
infect
appear
larg
degre
depend
recipi
sever
outcom
seen
immunocompromis
patient
food
drug
administr
took
number
action
lower
risk
transfus
transmiss
polici
manag
donor
prove
suspect
wnv
infect
implement
along
polici
product
quarantineretriev
notif
transfus
recipi
decemb
recommend
made
voluntarili
withdraw
hospit
blood
center
inventori
select
frozen
fig
major
wnvposit
blood
donat
origin
central
western
area
unit
state
consist
predict
westward
migrat
outbreak
hiv
hcv
blood
donat
screen
sampl
test
logist
reason
minipool
mpnat
process
lower
sensit
wnv
nat
assay
potenti
allow
breakthrough
transmiss
unit
lowlevel
viremia
overal
six
case
confirm
probabl
transfusiontransmit
wnv
document
median
age
affect
recipi
rang
four
wnv
enceph
one
west
nile
fever
one
critic
ill
patient
discern
wnvcompat
ill
despit
confirm
wnv
infect
receiv
multipl
blood
compon
includ
singl
infecti
unit
collect
summer
month
presumpt
transmit
donat
nonreact
pool
screen
test
posit
upon
retrospect
test
archiv
undilut
sampl
demonstr
capabl
wnv
transmit
transfus
low
level
estim
median
viremia
four
six
transmiss
case
plaqueform
unitsml
none
donor
report
wnv
ill
donat
document
breakthrough
infect
led
implement
strategi
convers
mpnat
singl
donat
nat
collect
region
high
wnv
activ
evidenc
clinic
case
report
mpnat
yield
rate
anoth
member
flavivirida
famili
also
transmit
human
bite
infect
mosquito
dengu
fever
viru
clinic
syndrom
often
caus
dengu
acut
flulik
ill
meningoenceph
rare
rarer
sever
complic
dengu
thought
requir
initi
infect
one
strain
viru
second
infect
differ
strain
dengu
widespread
tropic
region
world
includ
central
south
america
caribbean
island
number
case
region
increas
last
sever
decad
case
dengu
fever
rare
unit
state
canada
evid
local
mosquitoborn
transmiss
part
contin
date
transfusiontransmit
case
dengu
report
anywher
world
nevertheless
transfus
transmiss
arbovirus
wnv
may
expect
sinc
acut
viremia
day
perhap
week
follow
exposur
unit
state
arbovirus
would
like
eastern
equin
enceph
western
equin
enceph
st
loui
enceph
la
cross
enceph
bacteri
contamin
blood
compon
may
result
septic
reaction
even
death
transfus
recipi
wellrecogn
threat
sinc
earli
day
procedur
indic
bacteri
contamin
per
se
rise
continu
increas
use
platelet
blood
compon
associ
vast
major
septic
reaction
result
overal
increas
awar
bacteriainduc
transfus
reaction
inde
bacteri
sepsi
current
number
one
caus
acut
transfusionrel
mortal
link
infecti
agent
addit
declin
risk
hiv
hepat
transmiss
play
role
focus
attent
bacteri
contamin
reemerg
infecti
risk
transfus
state
risk
septic
reaction
classic
character
fever
chill
rigor
potenti
progress
septic
shock
far
greater
platelet
red
blood
cell
primari
reason
requir
roomtemperatur
storag
platelet
procedur
despit
restrict
storag
length
day
provid
far
better
growth
potenti
bacteria
refriger
red
blood
cell
storag
notabl
autolog
red
cell
transfus
also
associ
higher
risk
septic
reaction
administr
allogen
red
cell
find
readili
explain
gener
poorer
health
autolog
donor
higher
rate
unrecogn
bacteremia
applic
less
stringent
donor
select
criteria
autolog
donat
preval
bacteri
contamin
allogen
blood
compon
detect
cultur
compon
estim
approxim
platelet
red
cell
recent
nation
studi
unit
state
seriou
septic
reaction
report
approxim
platelet
transfus
million
red
cell
unit
transfus
rate
fatal
reaction
associ
platelet
red
cell
transfus
million
respect
owe
lack
clinic
awar
report
figur
undoubtedli
repres
low
estim
significantli
higher
rate
document
surveil
studi
singl
institut
microorgan
isol
contamin
red
cell
unit
includ
staphylococcu
epidermidi
serratia
liquefacien
pseudomona
speci
yersinia
enterocolitica
last
gramneg
endotoxinproduc
organ
remark
prefer
growth
colder
temperatur
ironenrich
environ
gramposit
skin
saprophyt
account
organ
contamin
platelet
concentr
remain
contamin
attribut
gramneg
organ
associ
occult
bacteremia
fatal
reaction
due
endotoxin
reaction
associ
gramneg
bacteria
platelet
concentr
contamin
bacillu
speci
escherichia
coli
klebsiella
speci
staphylococcu
aureu
epidermidi
serratia
marcescen
streptococcu
speci
account
fatal
reaction
moreov
although
bacteri
content
contamin
compon
time
collect
may
exceedingli
small
bacteria
propag
compon
storag
unlik
virus
result
mani
log
increas
concentr
releas
endotoxin
toxic
metabolit
minimum
bacteri
dose
platelet
concentr
need
produc
morbid
mortal
known
precis
although
bacteri
concentr
colonyform
unit
per
ml
consist
result
fatal
timehonor
approach
prevent
bacteri
contamin
includ
select
healthi
blood
donor
adher
strict
asept
techniqu
like
entri
point
bacteria
blood
donat
compon
prepar
transport
storag
infus
determin
effort
reduc
bacteri
contamin
septic
transfus
reaction
us
blood
center
transfus
servic
expect
implement
system
detect
limit
bacteri
contamin
platelet
earli
detect
system
requir
steril
sampl
platelet
compon
hour
phlebotomi
allow
viabl
bacteria
propag
detect
level
approxim
sampl
platelet
compon
inocul
autom
cultur
system
bacteria
detect
evid
oxygen
consumpt
carbon
dioxid
gener
enrich
growth
media
though
gener
success
method
natur
limit
due
slow
growth
rate
lack
easili
detect
metabol
product
pathogen
bacteria
sever
noncultur
bacteri
detect
system
also
describ
final
effect
prevent
bacteri
contamin
achiev
use
newer
skin
disinfect
solut
donor
phlebotomi
divers
first
ml
collect
blood
use
blood
type
infecti
diseas
screen
method
alon
combin
may
reduc
bacteri
load
skin
fragment
trap
phlebotomi
needl
subsequ
enter
blood
storag
contain
outlin
measur
aim
reduc
bacteri
contamin
blood
compon
like
signific
posit
impact
number
septic
transfus
reaction
concern
rais
howev
unwelcom
consequ
effort
consequ
could
includ
signific
increas
cost
frequent
platelet
shortag
due
higher
discard
rate
shorter
window
platelet
avail
distribut
hope
evid
lower
bacteri
contamin
rate
attribut
new
safeguard
permit
return
platelet
storag
period
standard
rise
rate
septic
reaction
forc
implement
current
storag
period
longer
distribut
period
platelet
could
least
partial
offset
financi
loss
rais
avail
essenti
blood
compon
tick
increasingli
recogn
vector
bacteri
zoonos
exampl
infect
transmit
human
includ
lyme
diseas
ehrlichios
rickettsios
report
tickborn
diseas
also
includ
viral
parasit
infect
among
babesiosi
discuss
parasit
risen
sharpli
unit
state
recent
year
increas
may
part
due
newli
institut
report
requir
tickborn
infect
state
health
agenc
one
may
specul
also
true
increas
caus
factor
widen
geograph
rang
tick
vector
unit
state
spread
residenti
area
tick
habitat
increas
popular
outdoor
sport
leisur
activ
bring
human
contact
vector
lyme
diseas
caus
spirochet
borrelia
burgdorferi
common
vectorborn
ill
unit
state
infect
diseas
transmit
human
bite
infect
tick
speci
ixod
scapulari
pacificu
spirochetemia
probabl
occur
postinfect
may
present
asymptomat
person
nonetheless
clinic
serolog
evid
transfusiontransmit
lyme
diseas
demonstr
cardiothorac
surgeri
patient
receiv
blood
collect
new
england
peak
deer
tick
season
date
confirm
report
transfusionacquir
lyme
diseas
tickborn
pathogen
may
transmit
transfus
includ
rickettsia
rickettsii
caus
organ
rocki
mountain
spot
fever
rmsf
anaplasma
phagocytophilum
formerli
ehrlichia
speci
agent
respons
human
granulocyt
ehrlichiosi
hge
acut
febril
ill
similar
rmsf
without
characterist
petechi
rash
singl
case
transfusiontransmit
rmsf
hge
report
late
respect
case
transmit
blood
unit
leukocytereduc
caus
agent
obligatori
intracellular
bacteria
recent
widespread
adopt
leukocyt
reduct
cellular
blood
compon
expect
lower
risk
transfus
transmiss
organ
varieti
parasit
infect
transmiss
transfus
commonli
malaria
chaga
diseas
babesiosi
discuss
detail
section
rare
report
human
transfusiontransmit
trypanosomiasi
african
sleep
sick
leishmaniasi
toxoplasmosi
microfilariasi
also
report
primarili
area
endem
organ
accord
natur
geograph
distribut
major
bloodborn
parasiteswith
except
babesiosi
found
area
temper
climatestransfusiontransmit
parasit
infect
primarili
concern
tropic
subtrop
countri
signific
proport
prospect
blood
donor
afflict
problem
compound
lack
resourc
infrastructur
mani
nation
interfer
effect
prevent
measur
howev
increas
intern
travel
tourism
human
migrat
countri
transfusiontransmiss
parasit
infect
endem
rais
concern
increas
transfusiontransmit
parasit
diseas
area
natur
affect
unit
state
malaria
occur
travel
militari
personnel
immigr
endem
countri
occasion
case
result
mosquito
transmiss
blood
transfus
organ
transplant
approxim
three
transfusionassoci
malaria
case
occur
per
year
unit
state
report
incid
case
per
million
unit
transfus
period
malari
parasit
plasmodium
falciparum
p
vivax
p
oval
p
malaria
maintain
viabil
red
blood
cell
rbc
store
c
platelet
concentr
store
room
temperatur
follow
rbc
cryopreserv
thaw
malaria
transmit
rbcfree
compon
fresh
frozen
plasma
cryoprecipit
incub
period
follow
transfus
rang
day
averag
day
clinic
present
includ
chill
fever
splenomegali
fatigu
nausea
vomit
headach
diarrhea
may
also
occur
anemia
may
sever
associ
hemoglobinemia
hemoglobinuria
especi
p
falciparum
infect
dehydrogenasedefici
rbc
resist
malaria
person
lack
duffi
rbc
antigen
refractori
p
vivax
infect
patient
sickl
cell
trait
partial
resist
p
falciparum
babesiosi
see
next
section
consid
differenti
diagnosi
endem
countri
vast
major
donor
recipi
previous
infect
recipi
administ
inexpens
prophylact
medic
transfus
prevent
transfusiontransmit
malaria
nonendem
countri
current
reli
deferr
blood
donor
emigr
return
malariaendem
region
imperfect
strategi
miss
infect
donor
exclud
mani
noninfect
peopl
donat
current
avail
laboratori
test
help
blood
donor
screen
set
impract
insensit
nonspecif
experiment
assay
combin
detect
antimalari
antibodi
antigen
natbas
assay
evalu
sever
countri
eg
great
britain
larg
immigr
popul
malariaendem
countri
preliminari
data
suggest
assay
may
prove
use
futur
babesiosi
malarialik
zoonosi
human
infect
incident
usual
bite
infect
tick
genu
ixod
case
human
babesiosi
north
america
caus
babesia
microti
preemin
speci
europ
b
divergen
babesia
infect
usual
asymptomat
associ
mild
flulik
symptom
howev
immunocompromis
individu
risk
lifethreaten
diseas
endem
northeast
upper
midwest
unit
state
diseas
recent
recogn
eastern
western
region
nation
well
case
transfusiontransmit
babesiosi
associ
either
rbc
platelet
transfus
report
unit
state
sinc
person
histori
babesiosi
defer
donat
blood
blood
donor
screen
test
effect
mean
detect
asymptomat
carrier
parasit
current
exist
american
trypanosomiasi
chaga
diseas
name
brazilian
physician
carlo
chaga
render
first
descript
consist
gener
asymptomat
mild
selflimit
acut
ill
resolv
within
week
chronic
phase
mark
cardiac
diseas
megacolon
achalasia
occur
infect
patient
long
latenc
period
caus
agent
flagel
protozoan
parasit
trypanosoma
cruzi
disord
limit
western
hemispher
widespread
latin
america
mexico
lower
half
south
american
contin
parasit
transmit
human
bite
cruziinfect
insect
reduviida
famili
effort
erad
vector
result
decreas
new
infect
endem
area
infect
person
maintain
lowlevel
intermitt
parasitemia
usual
persist
life
treatment
effect
erad
parasit
render
initi
acut
stage
vector
transmiss
unlik
outsid
endem
area
infect
latin
american
immigr
resid
unit
state
congenit
transmiss
may
contribut
reservoir
infect
person
among
immigr
commun
least
six
transfusionassoci
case
chaga
diseas
report
immunocompromis
patient
unit
state
canada
sinc
case
implic
donor
cruziinfect
latin
american
immigr
five
six
case
platelet
appear
transmit
compon
low
number
confirm
case
transfusiontransmit
chaga
diseas
north
america
may
mislead
involv
fulmin
diseas
immunosuppress
patient
transmiss
immunocompet
recipi
asymptomat
mild
acut
diseas
may
overlook
preval
cruzi
infect
among
unit
state
blood
donor
vari
wide
nationwid
estim
suggest
rate
donor
wherea
commun
larg
latin
american
immigr
popul
three
four
time
higher
rate
parasit
may
surviv
week
cold
storag
cryopreserv
blood
compon
risk
transmiss
cruzi
donor
resid
unit
state
remain
unclear
survey
recipi
receiv
blood
seroposit
donor
avail
test
none
evid
infect
nevertheless
transfusiontransmit
chaga
diseas
seen
rise
concern
unit
state
univers
screen
infect
blood
donat
may
implement
suitabl
screen
confirmatori
assay
licens
experi
south
america
blood
donor
routin
screen
test
antibodi
cruzi
antigen
demonstr
insuffici
sensit
specif
current
antibodi
test
suggest
improv
perform
may
achiev
newer
multiantigen
assay
pathogen
reduct
method
psoralen
agent
lesser
degre
leukocyt
reduct
offer
altern
approach
reduc
transfus
transmiss
parasit
leukocyt
reduct
appear
effect
wide
adopt
north
america
europ
reason
unrel
effect
transmiss
cruzi
reliabl
pathogen
reduct
method
still
essenti
limit
plasma
product
method
treatment
platelet
red
cell
compon
current
clinic
trial
classic
creutzfeldtjacob
diseas
cjd
rare
fatal
degen
neurolog
diseas
long
asymptomat
latent
period
first
describ
caus
agent
cjd
thought
expert
prion
protein
prpsc
abnorm
conform
normal
cellular
protein
prpc
induc
conform
transform
recruit
addit
prpc
prpsc
result
deposit
insolubl
precipit
neural
tissu
progress
dementia
cjd
one
varieti
prion
diseas
human
occur
spontan
rate
approxim
per
million
throughout
world
transmit
vertic
famili
condit
gerstmannstrausslerscheink
syndrom
horizont
ritualist
cannib
kuru
report
case
transmiss
classic
cjd
blood
transfus
nevertheless
long
incub
phase
diseas
demonstr
growth
hormon
transmiss
concern
aros
cjd
transmiss
could
occur
asymptomat
donor
blood
transfus
recipi
theoret
risk
led
establish
enhanc
donor
deferr
polici
base
iatrogen
exposur
famili
histori
diseas
potenti
cjd
carrier
sever
recent
epidemiolog
studi
confirm
earlier
studi
fail
establish
link
transfus
transmiss
cjd
although
still
regard
theoret
risk
emerg
consensu
classic
cjd
transmit
transfus
like
classic
cjd
variant
v
cjd
fatal
degen
neurolog
diseas
although
occur
younger
person
distinct
clinic
histopatholog
biochem
featur
includ
presenc
readili
detect
prion
protein
noncentr
nervou
system
lymphoreticular
tissu
appendix
spleen
tonsil
lymph
node
contrast
classic
cjd
vcjd
diseas
new
first
report
unit
kingdom
first
sever
year
investig
prove
caus
agent
vcjd
probabl
also
prion
agent
caus
bovin
spongiform
encephalopathi
bse
massiv
epidem
bse
occur
great
britain
earli
result
recycl
process
materi
offal
dead
sheep
cattl
food
meal
cattl
although
practic
stop
follow
appreci
bse
epidem
estim
cattl
alreadi
infect
bse
transmiss
bse
prion
human
occur
oral
consumpt
beef
cattl
product
contain
reticular
endotheli
neural
tissu
result
delay
outbreak
vcjd
unit
kingdom
fig
sever
observ
rais
theoret
concern
vcjd
could
spread
blood
transfus
includ
unknown
first
case
associ
human
diseas
vcjd
appear
sever
year
onset
bse
epidem
incid
vcjd
case
appear
level
reach
maximum
hope
follow
trend
bse
case
britain
concern
transfusiontransmit
vcjd
declin
well
potenti
larg
reservoir
asymptomat
carrier
vcjd
unit
kingdom
countri
signific
import
unit
kingdom
beef
product
possibl
long
incub
period
observ
transmiss
spongiform
encephalopathi
detect
vcjd
prion
protein
lymphoid
reticuloendotheli
cell
dendrit
cell
biolog
differ
prion
pathogenesi
vcjd
classic
cjd
make
unreason
extrapol
epidemiolog
data
lack
transfus
transmiss
classic
cjd
vcjd
studi
rodent
primat
anim
model
demonstr
infect
blood
implic
transfus
possibl
mode
transmiss
base
theoret
concern
vcjd
could
transmit
blood
transfus
initi
find
known
case
vcjd
could
trace
time
spent
unit
kingdom
polici
adopt
indefinit
deferr
person
spent
month
unit
kingdom
measur
predict
reduc
number
donor
potenti
infect
vcjd
approxim
result
deferr
approxim
otherwis
elig
donor
follow
discoveri
vcjd
case
continent
europ
deferr
polici
revis
includ
donor
spent
month
unit
kingdom
year
europ
sinc
april
definit
probabl
case
vcjd
report
unit
kingdom
addit
six
case
origin
franc
one
itali
four
addit
report
case
occur
elsewher
one
canada
unit
state
hong
kong
ireland
like
acquir
unit
kingdom
signific
chang
vcjd
epidemiolog
besid
fact
potenti
rate
increas
vcjd
unit
kingdom
predict
earli
worstcas
model
occur
possibl
vcjd
may
transmit
transfus
receiv
fresh
attent
recent
report
diseas
transfus
recipi
receiv
one
red
cell
compon
blood
donor
die
vcjd
year
donat
implic
donor
one
identifi
late
total
vcjd
case
britain
nation
cjd
surveil
unit
regist
recipi
becam
ill
year
transfus
die
vcjd
month
onset
symptom
diagnosi
confirm
examin
brain
tissu
statist
analysi
suggest
unlik
recipi
acquir
vcjd
unrel
transfus
possibl
rule
entir
definit
proof
vcjd
transmiss
blood
product
human
still
lack
estim
risk
transmiss
vcjd
transfus
emphas
aforement
report
far
one
suggest
direct
link
date
none
recipi
blood
compon
donat
individu
vcjd
unit
kingdom
registri
diagnos
diseas
donor
provid
blood
four
transfus
recipi
later
diagnos
vcjd
good
health
also
encourag
see
eventu
total
number
vcjd
case
declin
recent
report
project
rang
sever
thousand
total
case
howev
estim
critic
depend
nonquantifi
assumpt
underli
despit
recent
dramat
declin
risk
pose
ttv
particularli
hiv
hcv
concern
remain
contamin
blood
suppli
novel
emerg
virus
bacteria
parasit
infecti
protein
prion
immedi
improv
blood
safeti
expect
adopt
effect
method
prevent
bacteria
enter
blood
donat
mandatori
implement
bacteri
detect
system
overal
threat
novel
emerg
pathogen
difficult
address
multipl
agent
involv
risk
transmiss
transfus
advers
outcom
recipi
gener
well
defin
discuss
appropri
measur
protect
blood
suppli
agent
like
sar
vcjd
west
nile
viru
ongo
illustr
challeng
find
right
balanc
desir
mandat
safeti
need
maintain
adequ
afford
blood
suppli
past
experi
shown
exampl
closur
infecti
window
period
implement
new
molecular
assay
result
significantli
enhanc
safeti
high
cost
wherea
serolog
screen
donor
hbv
hiv
hcv
essenti
costneutr
ie
cost
test
offset
save
prevent
infectionsdiseas
cost
nat
test
exceed
million
per
infect
prevent
per
qualityadjust
life
year
save
pathogenreduct
method
current
develop
promis
effect
protect
ttv
pathogen
organ
except
prion
method
could
nearli
doubl
cost
platelet
rbc
compon
like
rais
new
safeti
concern
move
trial
stage
clinic
practic
besid
measur
aim
directli
keep
pathogen
enter
blood
suppli
adopt
restrict
donor
accept
criteria
expand
blood
donat
screen
pathogen
reduct
method
better
knowledg
understand
establish
potenti
infecti
risk
prerequisit
ration
protect
strategi
essenti
tool
surveil
studi
capabl
analyz
larg
blood
donor
popul
emerg
pathogen
nation
program
provid
resourc
infrastructur
need
monitor
blood
safeti
rapidli
assess
whether
extent
pathogen
transmit
transfus
import
surveil
activ
conduct
global
scale
outbreak
new
viral
diseas
often
start
develop
nation
mean
intern
commerc
travel
spread
region
world
overnight
proactiv
surveil
collabor
blood
collect
program
develop
countri
critic
barrier
event
effort
assist
local
agenc
establish
sustain
blood
collect
process
transfus
system
measur
protect
recipi
requir
transfus
develop
countri
long
run
enhanc
transfus
safeti
highincom
nation
assist
surveil
effort
expect
technolog
advanc
multiplex
nucleic
acid
test
system
microarraybas
detect
genotyp
system
viru
discoveri
identif
viral
gene
chip
integr
autom
surveil
system
detect
virus
infecti
agent
human
blood
given
number
varieti
flexibl
biolog
system
safe
predict
continu
encount
new
chang
infecti
agent
need
assess
potenti
threat
transfus
recipi
prevent
enter
blood
suppli
